Galena Biopharma, Inc. (GALE) Scheduled to Present at the 25th Annual Piper Jaffray Healthcare Conference

Galena Biopharma, a biopharmaceutical company focused on targeted treatments for cancer, today announced that President and CEO Mark J. Ahn, Ph.D., will be presenting a corporate update at the 25th Annual Piper Jaffray Healthcare Conference. The presentation will take place on Tuesday, December 3, 2013 at 8:10 a.m. ET at The New York Palace Hotel in New York, NY.

The presentation will be available on the Investors section of the company’s website at www.galenabiopharma.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html